TarSeer™ BRETSA™ Target Engagement System enables studies for difficult proteins early in drug discovery MADISON, Wis. — Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate proteins. The TarSeer™ BRETSA™ Target Engagement System is a novel bioluminescence resonance energy transfer-based […]

Vega instrument combines ultra-high-throughput, data quality, and assay flexibility for both traditional and AI-based drug discovery Enables primary screening with high-resolution binding First order and shipment slated for Q1 will be to a KOL at a top 10 pharma Salt Lake City, Utah – Carterra Inc., the leading provider of technologies enabling high-throughput biology, today announced […]

Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors Forms a global life sciences and diagnostics leader focused on high-volume testing in regulated applications Announces formation of four divisions: Waters Analytical Sciences, Waters Biosciences, Waters Advanced Diagnostics, and Waters Materials Sciences MILFORD, Mass. — Waters Corporation (NYSE: WAT) (“Waters”) today announced it has completed […]

New iNTApharma system enables rapid, native‑state size and concentration measurements with single‑particle sensitivity for viral, vesicle, and nanoscale bioparticle workflows BILLERICA, Mass. — Bruker Corporation today announced the launch of iNTApharma, a label‑free characterization platform that provides single‑particle sensitivity for the quantitative analysis of nanoscale bioparticles in native aqueous media. Introduced at SLAS 2026 in Boston,iNTApharma delivers size and concentration […]

New launches in high-content imaging, detection, and automation help labs accelerate drug discovery workflows from sample to insight WALTHAM, Mass. — Revvity, Inc. (NYSE: RVTY) announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate high-throughput drug discovery workflows. Making their debut at the conference in Boston, February 7-11, […]

ViaTag™ Haloalkane Ligands streamline workflows in a wide range of colors with lower overall cost compared to other wash-intensive haloalkane ligands. FREMONT, CA — Biotium, a leading provider of innovative fluorescent reagents and kits for life science research, announces the release of a new line of bright fluorescent ligands designed for flexible labeling of HaloTag? self-labeling protein […]

Establishing an R&D Footprint in India for Analytical and Measurement Solutions for Advanced Materials HORIBA India Private Limited (Head Office: New Delhi, India; President: Rajeev Gautam), a HORIBA Group company, announces that it has completed the acquisition of 100% of the shares of Pristine Deeptech Private Limited*1 (Head Office: Gujarat, India; CEO: Ashvani Kumar; hereinafter “Pristine […]

SSI Diagnostica Group strengthens life science portfolio for vaccine development and quality control with acquisition of US-based multiplexing company Copenhagen — SSI Diagnostica Group, a global company specializing in testing solutions for infectious diseases, has announced the acquisition of InDevR, a Colorado-based provider of advanced multiplexed solutions for vaccine testing and quality control. The addition strengthens […]

New York, New York — Peptide Hubs, a premier American-based supplier of high-purity research compounds, is thrilled to announce the official launch of six groundbreaking additions to its product catalog. This strategic expansion features some of the most sought-after compounds in modern biochemistry: Copper Peptide GHK-Cu, GHRP-6 Peptide, Adipotide Peptide, Selank, IGF-1 LR3, and Chonluten. […]

Received $350 Million in upfront cash at closing; Up to $425 Million in total proceeds inclusive of near-term earnout payments Approximately $550 Million in cash & cash equivalents on balance sheet at close, excluding potential future earnouts, to fuel inorganic growth strategy  Continuing Operations on track to achieve positive adjusted EBITDA in 2026 BOSTON, Mass. — Standard BioTools Inc. (NASDAQ: LAB) […]